Call for tender - Development Effectiveness Evaluation
BIO’s management contract provides that, each year, a sample of BIO’s interventions must be subject to an in-depth assessment of their development effects.
The ultimate goals of this assessment are:
- improving existing policies and practices and
- establishing new ones through lessons learning and evidence-base.
BIO has just published a call for tender for the next 3 Development Effectiveness Evaluations (period 2022- 2024), including a detailed Terms of Reference for the next evaluation that will focus on “BIO’s contribution to SDG10 – Reduced inequality and inclusive businesses”.
The Board of Directors of the Belgian Investment Company for Developing Countries (BIO) is pleased to announce the appointment of Joris Totté as the new Chief Executive Officer of the organization, effective as of March 1st, 2024. This appointment marks an exciting new chapter for BIO as it continues its mission of fostering sustainable development and economic growth in emerging markets.
BIO, the Belgian Investment Company for Developing Countries, and EDFI AgriFI, the EU-funded Agriculture Financing Initiative, have proudly announced their co-investment of a total of EUR 6 million in gebana Faso (GFA), a pivotal step towards enhancing integrated and sustainable food supply chains in the region.
BIO sincerely congratulates its colleagues at Kampani with its 500K investment, sourced by BIO, in Soprocopiv, a coffee cooperative in Butembe (North Kivu, DRC), .